- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00229827
Optimal Timing for Repair of Left to Right Shunt Lesions
March 14, 2012 updated by: Children's Healthcare of Atlanta
Optimal Timing for Repair of Left-to-Right Shunt Lesions
The purpose of this study is to determine the optimal timing for repair of left-to-right shunt lesions such as ventricular septal defects and atrioventricular canals.
Study Overview
Status
Terminated
Detailed Description
In the past, children with left-to-right shunt lesions such as ventricular septal defects and atrioventricular canal defects were palliated with a pulmonary artery band.
This prevented injury to the pulmonary vasculature while the child grew to a size where complete repair could be undertaken.
With the improvements in surgical technique and critical care, there is a push to do a primary complete repair for these defects at younger and younger ages.
These operations should be delayed as long as possible to allow for growth but not so long that there is unnecessary heart failure and medication requirements.
The primary aim is to determine the optimal timing for repair of left-to-right shunt lesions such as ventricular septal defects and atrioventricular canals.
The secondary aim is to define the criteria for failing medical anti-congestive heart failure therapy.
This study will be conducted through a retrospective chart review.
Study Type
Observational
Enrollment
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30322
- Children's Healthcare of Atlanta at Egleston
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients in the congenital surgery database
- Patients who have undergone repair of ventricular septal defects
- Patients who have undergone repair of atrioventricular canal defects
Description
Inclusion Criteria:
- Patients in the congenital surgery database
- Patients who have undergone repair of ventricular septal defects
- Patients who have undergone repair of atrioventricular canal defects
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Time Perspectives: Retrospective
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Brian Kogon, MD, Emory University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2005
Study Completion (Actual)
August 1, 2007
Study Registration Dates
First Submitted
September 13, 2005
First Submitted That Met QC Criteria
September 28, 2005
First Posted (Estimate)
September 30, 2005
Study Record Updates
Last Update Posted (Estimate)
March 16, 2012
Last Update Submitted That Met QC Criteria
March 14, 2012
Last Verified
May 1, 2007
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 05-092
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ventricular Septal Defects
-
Xijing HospitalCompletedVentricular Septal Defects
-
Abbott Medical DevicesCompletedMembranous Ventricular Septal DefectsUnited States
-
Nanjing Medical UniversityCompletedPediatric Ventricular Septal Defects
-
Abbott Medical DevicesActive, not recruitingVentricular Septal DefectsUnited States, Canada
-
Nationwide Children's HospitalCompletedTetralogy of Fallot (TOF) | Ventricular Septal Defects (VSD) | Atrioventricular Septal Defects (AVSD)United States
-
Chinese Academy of Medical Sciences, Fuwai HospitalUnknownPerimembranous Ventricular Septal DefectChina
-
Asklepion Pharmaceuticals, LLCCompletedAtrial Septal Defect | Atrioventricular Septal Defect | Ventricular Septal DefectUnited States
-
Occlutech International ABRecruitingMuscular Ventricular Septal DefectTurkey
-
Occlutech International ABActive, not recruitingPerimembranous Ventricular Septal DefectThailand, Germany, Ireland, Vietnam
-
Bark Technology LLPRecruitingCardiac Surgical Patients (CABG,Mammary Coronary Bypass Surgery,Plastic and Replacement of Valves, Atrial Septal Defect,Ventricular Septal Defect)Kazakhstan